7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 
      
    		                                         
      operating activities:
    		                                         
      net income before allocation to noncontrolling interest
    		50,900,000                                         
      adjustments to reconcile net income to net cash flows from operating activities:
    		                                         
      depreciation and amortization
    		29,000,000 27,100,000 21,600,000 23,400,000 24,700,000 20,200,000 18,500,000 18,600,000 20,500,000 9,900,000 28,600,000 29,100,000 28,800,000 32,400,000 28,600,000 29,700,000 29,000,000 29,200,000 31,600,000 32,200,000 32,400,000 33,000,000 29,900,000 29,300,000 27,900,000 28,600,000 27,700,000 35,900,000 27,800,000 28,400,000 27,900,000 18,700,000 18,500,000 18,100,000 17,400,000 16,600,000 16,700,000 17,600,000 16,500,000 17,100,000 16,000,000 
      stock-based compensation expense
    		3,300,000 3,100,000 2,900,000 2,900,000 2,800,000 2,600,000 2,300,000 2,900,000 2,700,000 -1,600,000 6,300,000 6,400,000 5,900,000 6,000,000 5,900,000 6,200,000 5,900,000 6,100,000 6,300,000 6,100,000 5,700,000 4,700,000 5,800,000 5,500,000 5,600,000 5,700,000 5,500,000 5,500,000 4,900,000 5,600,000 5,600,000 5,300,000 5,400,000 5,500,000 5,600,000 4,900,000 5,400,000 5,300,000 6,100,000 5,500,000 5,000,000 
      deferred income taxes
    		1,100,000 -12,300,000 -500,000 -17,300,000 -500,000 0 200,000 2,800,000 0 4,900,000 -100,000 -37,800,000 300,000 20,800,000 -900,000 15,200,000 -4,500,000 -200,000 300,000 10,600,000 0 1,400,000 6,100,000 -43,900,000 8,000,000 5,400,000 5,400,000 23,200,000 13,500,000 -1,700,000 12,700,000 86,300,000 6,000,000 10,100,000 -100,000  8,500,000 2,300,000 5,300,000 16,300,000 15,400,000 
      cash from operating working capital
    		6,200,000 13,300,000 -61,400,000 21,200,000 -13,400,000 -7,600,000 -50,800,000  24,500,000 178,300,000 -215,000,000 132,800,000 14,000,000 18,100,000 -167,100,000 66,200,000 -10,800,000 29,100,000 -54,800,000 47,300,000 45,900,000 69,600,000 -123,700,000 117,100,000 14,300,000 32,000,000 -203,400,000 57,600,000 4,500,000 -16,300,000 -29,500,000 92,000,000 45,100,000 -20,300,000 -62,800,000 61,400,000 46,700,000 900,000 -82,000,000  8,100,000 
      other
    		1,500,000 6,600,000 -3,400,000 -9,500,000 7,800,000 100,000 1,500,000   -4,300,000 1,500,000 -4,800,000 9,100,000 10,500,000 3,800,000 -6,000,000 1,000,000 -1,400,000 900,000 -5,100,000 -2,800,000 -1,200,000 1,300,000 -3,300,000 -1,000,000 6,700,000 -1,700,000 4,200,000 -800,000 10,200,000 2,400,000 4,800,000 -11,200,000 2,200,000 1,000,000  -2,500,000 -600,000 -1,700,000  -1,400,000 
      total provided by operating activities
    		92,000,000 62,800,000 -19,100,000 81,100,000 66,700,000 56,800,000 9,500,000 78,500,000 102,800,000   226,400,000 -427,000,000 55,200,000 -6,200,000 16,500,000 6,100,000 -41,000,000 50,200,000 101,400,000 131,500,000   222,900,000 118,500,000 152,900,000 -100,400,000 191,400,000 91,000,000 57,200,000 74,200,000 143,300,000 103,800,000 66,900,000 3,500,000 149,700,000 116,600,000   113,600,000 69,700,000 
      investing activities:
    		                                         
      payment for acquisitions, net of cash acquired
    		2,900,000   0                                      
      capital expenditures
    		-13,300,000 -7,000,000 -13,100,000 -10,800,000 -13,200,000 -8,900,000 -12,500,000 -15,000,000 -7,600,000 4,400,000 -12,900,000 -21,600,000 -11,600,000 -12,700,000 -12,500,000 -26,400,000 -11,400,000 -9,000,000 -4,900,000 -13,500,000 -7,100,000 -5,700,000 -7,800,000 -17,900,000 -14,800,000 -16,300,000 -19,800,000 -33,200,000 -31,600,000 -16,500,000 -27,500,000 -14,700,000 -13,500,000 -11,200,000 -9,600,000  -11,900,000 -15,600,000 -11,000,000  -8,100,000 
      free cash flows
    		                                         
      settlement of forward contracts
    		300,000 2,000,000 -500,000                                       
      total used for investing activities
    		-10,100,000 -399,000,000 -13,600,000 -13,600,000 -13,300,000 -278,600,000 -12,500,000 -15,000,000 -7,600,000 4,300,000 -12,800,000    -500,000 -800,000 -600,000   16,800,000 -62,800,000 -5,700,000 -177,400,000 -172,300,000 -4,500,000 -24,200,000 -20,000,000 -30,000,000 -6,500,000 -16,300,000 -699,500,000 2,400,000 -14,200,000 -65,300,000 -9,600,000  -11,800,000 -15,400,000 -10,500,000  -8,200,000 
      financing activities:
    		                                         
      dividends paid
    		-9,700,000 -9,800,000 -9,700,000 -9,200,000 -9,100,000 -9,200,000 -9,100,000 -7,900,000 -7,900,000 18,700,000 -26,600,000 -26,400,000 -26,400,000 -26,400,000 -26,700,000 -25,100,000 -25,300,000 -25,200,000 -25,000,000 -25,000,000 -25,000,000 -24,900,000 -25,500,000 -23,100,000 -23,400,000 -23,300,000 -23,400,000 -20,800,000 -20,900,000 -20,900,000 -20,900,000 -19,600,000 -19,500,000 -19,700,000 -19,600,000  -19,300,000 -19,300,000 -19,200,000  -19,100,000 
      proceeds from stock options exercised
    		900,000 700,000 600,000 300,000 1,100,000 300,000 1,600,000                                   
      payment of tax withholding on equity awards vested
    		-100,000 -200,000 -5,600,000 -400,000 -100,000 -200,000 -6,200,000                                   
      debt issuance costs
    		-3,500,000 0 -800,000     -400,000 -100,000 -1,200,000 -4,000,000         0 -100,000       0 0 0 -5,400,000           
      proceeds from revolving credit facility
    		36,500,000 242,000,000 106,000,000 138,000,000 30,500,000 250,000,000 30,000,000 0            0 0                     
      repayment of revolving credit facility
    		-71,500,000 -289,500,000 -52,500,000 -78,000,000 -95,500,000 -60,000,000 -5,000,000 0                                  
      proceeds from term loan
    		0       0 0 0 350,000,000 0        0 0                     
      repayment of term loan
    		-4,100,000   -101,700,000 -1,300,000 -1,300,000 -700,000 -70,000,000 -125,000,000 350,000,000 -400,000,000     0 0                         
      total provided by financing activities
    		-51,500,000 306,800,000 38,000,000 -53,700,000 -74,400,000 179,600,000 10,600,000     -13,300,000       -44,900,000 -132,200,000 -127,600,000 180,600,000 134,300,000  -23,700,000 -78,600,000 33,300,000  -75,200,000 -346,700,000 550,900,000   -14,700,000 -6,800,000   7,100,000 7,900,000   
      effect of exchange rates on cash, cash equivalents and restricted cash
    		-100,000 8,500,000 6,700,000 -14,400,000 11,900,000 -1,600,000 -7,900,000                                   
      increase in cash, cash equivalents and restricted cash
    		  12,000,000                                       
      cash, cash equivalents and restricted cash at beginning of period1
    		0 0 173,400,000                                       
      cash, cash equivalents and restricted cash at end of period2
    		30,300,000 -20,900,000 185,400,000                                       
      decrease in cash, cash equivalents and restricted cash
    		    -9,100,000 -43,800,000 -300,000                                   
      net income attributable to common shareholders
    		  21,700,000 57,600,000 47,100,000 41,600,000 37,800,000 49,500,000 51,900,000 -18,800,000 105,700,000  -59,300,000      108,400,000 46,800,000 56,600,000 14,800,000 62,800,000 -112,600,000 72,500,000 91,000,000 82,400,000 89,200,000 97,000,000 80,700,000 68,700,000 -28,700,000 68,200,000 69,200,000 63,100,000 -64,000,000 63,500,000 68,300,000 55,000,000 65,200,000 56,900,000 
      unrealized loss on forward contracts
    		                                         
      defined benefit plans and postretirement credit
    		   -200,000 -1,600,000     -5,700,000 5,300,000 9,200,000 -3,900,000 -3,900,000 -2,700,000 -2,000,000 -1,800,000 -2,500,000 -1,700,000 -2,600,000 -1,800,000 -900,000 -1,800,000 -300,000 3,600,000 -2,000,000 -2,000,000 -3,400,000 -3,900,000 -3,800,000 -3,900,000 -2,200,000 -2,100,000 -2,100,000 -2,100,000  -2,500,000     
      repayment of long-term debt
    		       0 0               -94,900,000 -1,700,000 -1,400,000 -1,400,000 -1,400,000 -800,000 -200,000,000 -250,000,000           
      net transfers to crane
    		       0 0                                 
      cash and cash equivalents at beginning of period
    		   0 0 0 227,200,000 0 0 -426,900,000 657,600,000 0 0 0 478,600,000  0 0 551,000,000 0 0 0 393,900,000 0 0 0 343,400,000 0 0 0 706,200,000 0 0 0 509,700,000 0 0 0 363,500,000 0 0 
      cash, cash equivalents and restricted cash at end of period
    		                                         
      detail of cash from operating working capital
    		                                         
      accounts receivable
    		                  -55,100,000 14,900,000 5,700,000 105,900,000 12,000,000 27,900,000 5,800,000 35,500,000 -65,400,000 43,900,000 -21,800,000 -67,400,000 50,100,000 11,900,000 3,800,000 -6,200,000 -19,600,000 26,700,000 5,300,000 -9,400,000 -28,800,000 29,900,000 -4,500,000 
      inventories
    		                  -1,600,000 28,700,000 26,300,000 11,500,000 -31,100,000 40,600,000 -22,600,000 3,600,000 -29,900,000 -7,600,000 600,000 -19,200,000 -12,600,000 23,600,000 -3,900,000 -1,100,000 -12,200,000 23,700,000 16,000,000 7,100,000 -21,900,000  -19,900,000 
      other current assets
    		                  -19,000,000 13,000,000 4,700,000 -6,400,000 -17,100,000 -5,000,000 10,400,000 900,000 -7,600,000 1,000,000 -600,000 -7,900,000 -3,900,000 -400,000 1,900,000    1,600,000 -800,000 -2,900,000  600,000 
      accounts payable
    		                  16,900,000 -11,700,000 -4,100,000 -25,700,000 -61,100,000 45,800,000 -15,000,000 11,700,000 -65,900,000 66,200,000 -7,100,000 31,500,000 -53,600,000 40,200,000 -1,700,000 4,000,000 -25,000,000 26,900,000 -3,100,000 8,100,000 -26,400,000 4,800,000 12,400,000 
      accrued liabilities
    		                  -18,700,000 24,500,000 17,900,000 -11,100,000 -26,500,000 3,300,000 31,600,000 -24,500,000 -45,600,000 -29,900,000 33,000,000 44,600,000 -6,800,000 19,900,000 38,400,000 -4,600,000 -22,900,000 -3,000,000 15,700,000 3,800,000 -6,900,000 -20,700,000 18,700,000 
      u.s. and foreign taxes on income
    		                  22,700,000 -22,100,000 -4,600,000 -4,600,000 100,000 4,500,000 4,100,000 4,800,000 11,000,000 -16,000,000 400,000 2,100,000 -2,700,000 -3,200,000 6,600,000 -11,700,000 16,900,000  11,200,000 -7,900,000 4,900,000 -6,600,000 800,000 
      total
    		                  -54,800,000 47,300,000 45,900,000 69,600,000 -123,700,000 117,100,000 14,300,000 32,000,000 -203,400,000 57,600,000 4,500,000 -16,300,000 -29,500,000 92,000,000 45,100,000 -20,300,000 -62,800,000 61,400,000 46,700,000 900,000 -82,000,000 30,500,000 8,100,000 
      supplemental disclosure of cash flow information:
    		                                         
      interest paid
    		                  9,900,000 18,600,000 11,400,000 15,800,000 8,000,000 15,700,000 7,700,000 14,900,000 9,100,000 14,800,000 10,800,000 17,500,000 4,400,000 17,300,000 1,000,000 17,000,000 700,000 17,700,000 800,000 17,500,000 800,000 17,400,000 800,000 
      income taxes paid
    		                  5,700,000 4,500,000 23,400,000 7,300,000 11,300,000 5,200,000 8,600,000 18,600,000 5,500,000 22,100,000 6,800,000 23,900,000 5,600,000 28,300,000 15,900,000 32,000,000 7,900,000 16,200,000 11,700,000 30,400,000 11,500,000 16,500,000 11,000,000 
      unpaid capital expenditures
    		                                         
      balance december 31, 2021
    		                                         
      net income
    		                                         
      stock-based compensation
    		                                         
      changes in pension and postretirement plan assets and benefit obligation, net of tax
    		                                         
      currency translation adjustment
    		                                         
      balance december 31, 2022
    		                                         
      cash dividends
    		                                         
      dividend from crane
    		                                         
      reclassification of crane net investment to common stock, treasury stock and capital surplus
    		                                         
      exercise of stock options, net of shares reacquired of 158,132 shares
    		                                         
      stock-based compensation reclassificationa
    		                                         
      impact from settlement of share-based awards, net of shares acquired
    		                                         
      balance december 31, 2023
    		                                         
      exercise of stock options, net of shares reacquired of 118,896 shares
    		                                         
      balance december 31, 2024
    		                                         
      proceeds from settlement of forward contracts
    		    0                                     
      cash, cash equivalents and restricted cash at end of period1
    		    -9,100,000 -43,800,000 226,900,000                                   
      payment for acquisition, net of cash acquired
    		                                         
      1 includes both current and non-current balances of restricted cash. current restricted cash, included within “other current assets” in our unaudited consolidated and combined condensed balance sheets, was 0.1 million and 0.0 million as of march 31, 2024, and march 31, 2023, respectively. non-current restricted cash, included within “other assets” in our unaudited consolidated and combined condensed balance sheets, was 6.2 million and 0.0 million as of march 31, 2024, and march 31, 2023, respectively.
    		                                         
      non-cash restructuring gains
    		                                         
      proceeds from disposition of property
    		                                         
      stock options exercised, net of shares reacquired
    		       2,300,000 200,000 -10,900,000 12,800,000 13,100,000 1,300,000 1,100,000 700,000 4,300,000 4,700,000                         
      total used for financing activities
    		       -76,000,000 -132,800,000 24,100,000 -67,800,000                     -17,700,000          
      effect of exchange rates on cash and cash equivalents
    		       10,700,000 -10,300,000 -600,000 4,000,000 23,300,000 -32,100,000 -25,500,000 -5,100,000  -8,500,000 3,000,000 -7,500,000 20,400,000 11,400,000 2,300,000 -12,500,000 10,100,000 -8,500,000 100,000 500,000 -4,700,000 -3,900,000 -18,300,000 10,500,000 6,000,000 14,900,000 17,600,000 8,000,000  1,400,000 -6,600,000 11,100,000  -8,800,000 
      increase in cash and cash equivalents
    		       -1,800,000 -47,900,000     343,400,000 -171,400,000  64,100,000 -191,700,000 27,400,000 6,400,000 -47,500,000   5,100,000    19,800,000    134,000,000 62,900,000   73,400,000 27,400,000   28,300,000 8,900,000 
      cash and cash equivalents at end of period
    		       -1,800,000 -47,900,000 -233,300,000 510,200,000 219,000,000 -212,000,000 343,400,000 307,200,000  64,100,000 -191,700,000 578,400,000 6,400,000 -47,500,000 289,300,000 302,800,000 5,100,000 81,800,000 50,200,000 256,800,000 19,800,000 5,400,000 -324,100,000 642,300,000 134,000,000 62,900,000 4,500,000 504,800,000 73,400,000 27,400,000 54,900,000 354,000,000 28,300,000 8,900,000 
      defined benefit plans and postretirement contributions
    		          -1,800,000 -2,500,000 -10,700,000 -5,800,000 -2,800,000 -6,600,000 -5,600,000 -1,400,000 -15,800,000 -25,300,000 -800,000 -800,000 -1,500,000 -2,700,000 -900,000 -800,000 -4,300,000 -4,000,000 -39,300,000 -12,000,000 -4,500,000 -3,300,000 -6,100,000 -1,700,000 -2,100,000  -2,000,000 -2,200,000 -2,200,000  -7,200,000 
      environmental payments, net of reimbursements
    		          -1,300,000 -400,000 -400,000 -3,700,000 -1,300,000 -1,200,000 -1,000,000 -2,100,000 -1,500,000 -1,300,000 800,000 -1,000,000 -2,700,000 -1,700,000 -2,500,000 -2,400,000 -1,600,000 -900,000 -1,200,000 -1,900,000 -2,300,000   -700,000 -2,000,000  -1,600,000 -4,600,000 -2,000,000  -6,000,000 
      asbestos related payments, net of insurance recoveries
    		           0 -5,900,000 -15,900,000 -7,500,000 -15,300,000 -9,400,000 -9,400,000 -10,800,000 -7,400,000 -4,500,000 -7,500,000 -11,700,000  -11,100,000 -8,200,000 -9,700,000  -11,500,000 -32,000,000 -2,900,000   -13,500,000 -14,700,000  -15,800,000 -14,900,000 -10,800,000  -11,400,000 
      total used for operating activities
    		          -70,800,000            -35,500,000                -18,000,000   
      proceeds from disposition of capital assets
    		          100,000 4,200,000 0   300,000 -100,000 8,900,000 14,500,000 600,000 1,200,000 300,000 2,400,000 1,800,000 400,000   600,000 800,000 200,000 300,000     100,000 100,000 200,000 500,000 2,500,000 0 
      reacquisition of shares on open market
    		           0 0 -27,900,000 -175,800,000     0 0 0 -70,000,000     -25,100,000 0   0         0 
      net borrowings from issuance of commercial paper with maturities of 90 days or less
    		             15,400,000 104,000,000                           
      decrease in cash and cash equivalents
    		          -147,400,000            -91,100,000   50,200,000 -86,600,000   -324,100,000 -63,900,000    -4,900,000    -9,500,000   
      net income before allocations to noncontrolling interests
    		                                         
      non-cash loss on divestiture of asbestos-related assets and liabilities
    		                                         
      gain on sale of business
    		           0 -3,800,000                             
      gain on sale of property
    		               0 0 -5,800,000 -12,700,000                       
      divestiture of asbestos-related assets and liabilities
    		           0                              
      proceeds from sale of business
    		           0 3,800,000                             
      purchase of marketable securities
    		               0 0 0 -10,000,000 -30,000,000    0 0                 
      proceeds from sale of marketable securities
    		               0 0 10,000,000 30,000,000     0                  
      payment for acquisition - net of cash acquired
    		                    3,100,000 -300,000 -172,000,000      24,300,000 0 -672,300,000           
      total provided by investing activities
    		           -17,400,000 -7,800,000      29,600,000                       
      proceeds from issuance of commercial paper with maturities greater than 90 days
    		                   0 0 81,300,000 170,000,000                   
      repayments of commercial paper with maturities greater than 90 days
    		               0 0 0 -27,100,000 -108,100,000 -92,100,000                     
      net repayments from issuance of commercial paper with maturities of 90 days or less
    		                                         
      repayments of revolving credit facility
    		                                         
      loss on divestiture of asbestos-related assets and liabilities
    		                                         
      operating activities from continuing operations:
    		                                         
      net income from continuing operations attributable to common shareholders
    		              94,700,000 68,800,000 111,400,000                         
      total provided by operating activities from continuing operations
    		              -49,300,000 155,000,000 114,200,000                         
      investing activities from continuing operations:
    		                                         
      total provided by investing activities from continuing operations
    		              -12,500,000 -26,100,000 -11,500,000                         
      financing activities from continuing operations:
    		                                         
      total used for financing activities from continuing operations
    		              -97,800,000                           
      discontinued operations:
    		                                         
      increase in cash and cash equivalents from discontinued operations
    		              -6,700,000 15,700,000 5,500,000                         
      asbestos provision
    		                                         
      environmental provision
    		                                         
      loss on deconsolidation of joint venture
    		                        0 0 1,200,000               
      realized gain on marketable securities
    		                       0                  
      impact of deconsolidation of joint venture
    		                       0 0 0 -200,000               
      repayment of short-term debt
    		                           0 0 0 -100,000,000           
      proceeds from issuance of long-term debt
    		                           13,100,000 4,100,000             
      net (repayments) proceeds from issuance of commercial paper with maturities of 90 days or less
    		                                         
      total provided by financing activities from continuing operations
    		               -117,100,000 -35,600,000                         
      repayments from issuance of commercial paper with maturities of 90 days or less
    		                                         
      net proceeds (repayments) from issuance of commercial paper with maturities of 90 days or less
    		                                         
      stock options exercised - net of shares reacquired
    		                  7,200,000  3,600,000 500,000 100,000  1,400,000 1,600,000 -400,000  7,500,000 500,000 4,500,000 4,500,000   12,800,000 16,800,000 7,400,000 3,600,000 -1,400,000 1,600,000 300,000 
      net proceeds from issuance of commercial paper with maturities of 90 days or less
    		                      14,500,000                   
      net borrowings under revolving credit facility
    		                      45,200,000                   
      detail of cash from operating working capital:
    		                                         
      noncontrolling interest in subsidiaries' earnings
    		                                         
      net income before allocation to noncontrolling interests
    		                   46,900,000 56,600,000 14,800,000 62,800,000  72,600,000 91,000,000 82,500,000  97,000,000 80,700,000 68,700,000  68,500,000 69,300,000 63,300,000  63,700,000 68,400,000 55,200,000  57,200,000 
      payments for acquisitions, net of cash acquired
    		                                         
      proceeds from issuance of short-term debt
    		                           0 0             
      noncontrolling interests in subsidiaries’ earnings
    		                        100,000 0 100,000      300,000 100,000 200,000  200,000 100,000 200,000  300,000 
      proceeds received from issuance of long-term debt
    		                        0 0 3,000,000    550,000,000           
      net repayments of commercial paper with maturities of 90 days or less
    		                                         
      repayments from revolving credit facility
    		                    0                     
      unrealized gain on marketable securities
    		                                         
      gain on deconsolidation of joint venture
    		                                         
      gain on sale of property related to facility consolidation
    		                                         
      payments for asbestos-related fees and costs, net of insurance recoveries
    		                                         
      proceeds received from issuance of short-term debt
    		                              100,000,000           
      proceeds received from issuance of commercial paper
    		                              272,700,000           
      proceeds from commercial paper
    		                          55,500,000               
      impact of deconsolidation of joint ventures
    		                                         
      repayment of commercial paper
    		                                         
      proceeds from issuance of commercial paper
    		                            -65,100,000         22,800,000 28,500,000   
      restructuring - non cash
    		                                       500,000 100,000 
      excess tax benefit from stock-based compensation
    		                                         
      repayment of credit facility
    		                                         
      (repayments) proceeds from issuance of commercial paper - net
    		                                         
      detail of cash from working capital:
    		                                         
      environmental payments - net of reimbursements
    		                                         
      asbestos related payments - net of insurance recoveries
    		                                         
      payments for acquisitions - net of cash acquired
    		                                -700,000         
      gain on divestiture
    		                                         
      proceeds from divestitures
    		                                         
      proceeds from acquisitions
    		                                         
      excess tax shortfall from stock-based compensation
    		                                         
      (repayments) proceeds from issuance of commercial paper
    		                                         
      defined benefit plans and postretirement expense
    		                                      -2,400,000   
      defined benefit plans and postretirement (credit) expense
    		                                         
      proceeds from (payments for) acquisitions
    		                                         
      proceeds received from credit facility
    		                                         
      proceeds from issuance of commercial paper - net
    		                                         
      proceeds received from issuance of long-term notes
    		                                         
      proceeds from divestiture
    		                                         
      proceeds from acquisition
    		                                         
      excess tax benefit (shortfall) from stock-based compensation
    		                                        0 
      defined benefit plans and postretirement (benefit) expense
    		                                         
      proceeds from (repayment of) credit facility
    		                                         
      proceeds from issuance (repayment) of commercial paper
    		                                         
      change in short-term debt
    		                                         
      environmental charge
    		                                         
      net changes in other short-term debt
    		                                         
      equity:
    		                                         
      debt:
    		                                         
      net decrease in short-term debt
    		                                         
      balance january 1, 2010
    		                                         
      reacquisition on open market 1,396,608 shares
    		                                         
      exercise of stock options, net of shares reacquired, 1,040,684
    		                                         
      stock option amortization
    		                                         
      tax benefit — stock options and restricted stock
    		                                         
      restricted stock
    		                                         
      balance december 31, 2010
    		                                         
      reacquisition on open market 1,706,973 shares
    		                                         
      exercise of stock options, net of shares reacquired, 1,101,817
    		                                         
      balance december 31, 2011
    		                                         
      reacquisition on open market 1,271,592 shares
    		                                         
      exercise of stock options, net of shares reacquired, 672,960
    		                                         
      balance december 31, 2012
    		                                         
      noncontrolling interest in subsidiaries’ earnings
    		                                         
      gain on disposition of capital assets and divestitures
    		                                         
      cash (used for) provided from operating working capital
    		                                         
      total provided from operating activities
    		                                         
      payments for acquisitions, net of cash and liabilities assumed of 3,206 in 2010
    		                                         
      stock options exercised — net of shares reacquired
    		                                         
      excess tax benefit — exercise of stock options
    		                                         
      net decrease in short-term borrowings
    		                                         
      effect of exchange rate on cash and cash equivalents
    		                                         
      cash and cash equivalents at beginning of year
    		                                         
      cash and cash equivalents at end of year
    		                                         
      detail of cash
    		                                         
      balance january 1, 2009
    		                                         
      exercise of stock options, net of shares reacquired, 110,050
    		                                         
      comprehensive income
    		                                         
      balance december 31, 2009
    		                                         
      comprehensive loss
    		                                         
      restructuring — non cash
    		                                         
      gain on divestitures
    		                                         
      payments for acquisitions, net of cash and liabilities assumed of 3,206 in 2010 and 16,716 of cash acquired in 2008
    		                                         
      balance january 1, 2008
    		                                         
      reacquisition on open market 2,290,976 shares
    		                                         
      exercise of stock options, net of shares reacquired, 426,346
    		                                         
      restricted stock awarded, 193,045 shares
    		                                         
      balance december 31, 2008
    		                                         
      reacquisition on open market 1,396,608
    		                                         
      asbestos charge
    		                                         
      gain on sale of joint venture
    		                                         
      (gain) loss on divestitures
    		                                         
      income from joint venture
    		                                         
      cash provided from (used for) operating working capital
    		                                         
      proceeds from sale of equity investment
    		                                         
      payments for acquisitions, net of cash and liabilities assumed of 16,716 in 2008 and 16,829 in 2007
    		                                         
      net increase in short-term borrowings
    		                                         
      detail of cash provided from
    		                                         
      balance january 1, 2007
    		                                         
      reacquisition on open market 1,247,130 shares
    		                                         
      exercise of stock options, net of shares reacquired, 845,498
    		                                         
      restricted stock awarded, 90,365 shares
    		                                         
      change in pension and postretirement plan assets and benefit obligation, net of tax
    		                                         
      balance december 31, 2007
    		                                         
      payments for acquisitions, net of cash and liabilities assumed of 16,716 in 2008, 16,829 in 2007 and 33,219 in 2006
    		                                         
      repayments of long-term debt
    		                                         
      issuance of long-term debt
    		                                         
      total (used for) provided from financing activities
    		                                         
      gain on sale of facility — foundry restructuring
    		                                         
      loss/(gain) on divestitures
    		                                         
      refund (payment) associated with terminated master settlement agreement
    		                                         
      payments for acquisitions, net of cash and liabilities assumed of 16,829 in 2007, 33,219 in 2006 and 388 in 2005
    		                                         
      proceed from divestitures
    		                                         
      net increase in short-term debt
    		                                         
      total provided from (used for) financing activities
    		                                         
      payments for acquisitions, net of cash and liabilities assumed of 33,219 in 2006, 388 in 2005 and 11,060 in 2004
    		                                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.